Related Experiment Video
Updated: May 1, 2026

Generation and Genetic Manipulation of Human Cervical Organoids
Published on: March 10, 2026
Current aims and challenges associated with cervical cancer prevention
Neal M Lonky1, Kristine R Penner, Justin T Diedrich
1*Southern California Permanente Medical Group, Kaiser Permanente, Anaheim, California †Department of Obstetrics and Gynecology, University of California, Irvine, California ‡Department of Gynecologic Oncology, University of California Irvine School of Medicine, Irvine, California §Washington University in St. Louis, St Louis, Missouri.
Current cervical cancer screening methods identify many individuals without high cancer risk. This raises questions about aggressive treatment for young patients and personalized management strategies for higher-risk individuals.
Area of Science:
- Gynecology
- Oncology
- Preventive Medicine
Background:
- Cervical cancer screening aims to detect premalignant and malignant lesions.
- Current screening protocols may lead to overdiagnosis and overtreatment, particularly in younger populations.
Purpose of the Study:
- To review current cervical cancer screening modalities.
- To evaluate the implications of current screening on patient management, especially for younger individuals.
- To question the generalized application of guidelines to diverse risk groups.
Main Methods:
- Review of existing literature on cervical cancer screening techniques.
- Analysis of outcomes for patients undergoing screening and subsequent triage.
- Examination of treatment-related morbidities in relation to screening positivity.
Main Results:
- The majority of positive screening tests do not progress to life-threatening cervical cancer.
- Younger patients often undergo aggressive therapies following screening triage.
- Current guidelines may not adequately differentiate management for average-risk versus high-risk patients.
Conclusions:
- There is a need to reassess cervical cancer screening strategies to minimize overtreatment.
- Personalized management approaches considering individual risk stratification are warranted.
- Clinical guidelines should be critically evaluated for their applicability to diverse patient populations and risk profiles.
More Related Videos
06:57Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Aims Of Nursing
Preventive Healthcare Services
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...